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ABSTRACT 
 
 Major mastitis pathogens such as Staphylococcus aureus, Streptococcus agalactiae, 
Streptococcus uberis, Streptococcus dysgalactiae and the coliforms are usually considered more 
virulent and damaging to the udder than minor mastitis pathogens such as Corynebacterium bovis and 
coagulase-negative staphylococci (CNS). The current literature contains a number of studies detailing 
analyses with conflicting results as to whether intramammary infection (IMI) with the minor 
pathogens reduces, increases, or has no effect on the risk of a quarter acquiring a new intramammary 
infection (NIMI) with a major pathogen. In order to investigate the available scientific evidence 
regarding the impact of IMI with minor pathogens on the acquisition of NIMI with major pathogens, a 
systematic review and meta-analysis were conducted. All extant English- and French-language 
literature in electronic databases was searched and all publications cited by relevant papers were 
investigated. Results from a total of 68 studies were extracted from 38 relevant papers. Random-effects 
models were used to investigate the effects of CNS and C. bovis on acquisition of new IMI with any of 
the major pathogens, as well as individually for the minor pathogens and S. aureus. Significant 
heterogeneity among studies exists, some of which could be accounted for using meta-regression. 
Overall, observational studies showed no effect, while challenge studies showed strong and significant 
protective effects, specifically when major pathogens were introduced into the mammary gland via 
methods by-passing the teat end. Underlying risk can account for a number of unmeasured factors, and 
studies with higher underlying risk found more protective effects of minor pathogens. Larger doses of 
challenge organisms reduced the protective effect of minor pathogens, and studies with more stringent 
diagnostic criteria for pathogen IMI also identified less protection. Smaller studies (those utilizing 
fewer than 40 cows) also showed a greater protective effect than larger studies. 
 
Keywords: major pathogens, minor pathogens, protective effect, meta-analysis 
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INTRODUCTION 
 
 Major mastitis pathogens such as Staphylococcus aureus, Streptococcus agalactiae, 
Streptococcus uberis, Streptococcus dysgalactiae and the coliforms are usually considered more 
virulent and damaging to the udder than minor mastitis pathogens such as Corynebacterium bovis and 
coagulase-negative staphylococci (CNS). A number of studies conducted over the past 6 decades 
investigating the effects of minor pathogens on the risk of acquisition of major pathogen infections 
have yielded contradicting results (Green et al., 2002; Pyörälä and Taponen, 2009). Studies vary 
widely in methodology. Experimental challenge studies involve inoculation of quarters with both 
minor and major pathogens or natural infections with minor pathogens and experimentally induced 
infections with major pathogens. Infections have been introduced either by intra-cisternal infusion, 
inoculation into the teat canal or teat end exposure. Observational studies also exist that examine the 
interaction between natural infections with these 2 groups of pathogens in field settings. 
 Extreme heterogeneity exists among studies accounting for these interactions, and certain 
shortcomings of publications on this topic are recognized. Although a large number of mastitis 
pathogens exist in nature, only a few strains of pathogens are typically tested in laboratory settings. 
Also, one of the roles of minor pathogens may be to prevent entry of major pathogens into the 
mammary gland, a situation which is certainly overcome by direct infusion of pathogens into the teat 
FDQDORUFLVWHUQ'HILQLWLRQRIDQ,0,SURYLGHVVRPHGLIILFXOWLHVDVHYHQPDVWLWLVµH[SHUWV¶DUHRIWHQLQ
disagreement over how infection is defined (Andersen et al., 2010). Numerous issues may affect the 
interactions of minor and major pathogens within a quarter, cow or herd. Differences such as 
anatomical features, immunological characteristics, previous infections and other alterations in 
environment may play a role in susceptibility. Cow-level factors such as breed, season of calving, age 
and stage of lactation may have an effect, and herd-level factors such as overall pathogen profile 
undoubtedly play a role, especially when random allocation of pathogens is not used. Studies that fail 
to take into account these factors leave themselves open to a great number of confounding issues. 
 Narrative reviews bring together the diversity in results that exist in the literature (Pyörälä and 
Taponen, 2009; Pyörälä et al., 2011), and a number of papers have reviewed the effects of minor 
pathogen infections on acquisition of major pathogen NIMI, whether as a section of an all-
encompassing literature review or in the introduction or discussion of a primary research article 
investigating such interactions. These reviews are helpful in summarizing some of what has been 
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shown to date, but none exist that utilize a systematic or statistical methodology in the processes of 
identification of relevant studies, assessment of methodology and outcomes, and synthesis of the 
information covered. Many of the narrative reviews in the primary research literature focus on results 
similar to those obtained in the trial being described, in order to support such results as having been 
previously identified. With such diversity in findings, however, this is almost always possible to some 
degree, even when the authors are citing trials conducted 50 years previous and involving only a 
handful of subjects. A systematic review, on the other hand, uses a transparent method to identify 
relevant literature, extract the required information and summarize and synthesize the results of the 
included studies (Sargeant et al., 2006). Qualitative methods can be used to investigate the differences 
or similarities between studies, while quantitative methods seek to combine study results and/or 
investigate factors contributing to heterogeneity among studies. Due to the diverse publications and 
previous research concerning the effect of minor pathogens in bovine mastitis, a systematic review and 
meta-analysis was selected to shed further light on the information available on this topic. The 
objective of this paper was specifically to investigate the impact of minor pathogen IMI on the 
acquisition of new major pathogen IMI in the bovine udder. Because substantial heterogeneity among 
studies was expected, the specific aim was to quantify and describe the sources of heterogeneity rather 
than provide an overall estimate of the effect of minor pathogen IMI on major pathogen NIMI. 
 
MATERIALS AND METHODS 
 
Literature Search 
 An online literature search was conducted, consulting PubMed, CAB Abstracts, Agricola and 
Google Scholar. To identify papers referring to minor pathogens, keywords such as minor, 
Corynebacter* and coagulase-negative staphylococc* were used. In order to include papers 
referencing major pathogens, major, Staph* aureus, Staph*, Strep* and coliform* keywords were also 
used. These were then combined (using AND statements) with the keywords mastitis, risk and protect* 
in order to identify studies investigating these interactions. Studies in English or French were 
considered, and were drawn from peer-reviewed journals, conference proceedings, book chapters and 
theses. Upon initial reading RIVDOLHQWDUWLFOHVE\WKHSULPDU\DXWKRUZRUNFLWHGLQWKHµ5HIHUHQFHV¶
section that appeared to deal with the interactions between minor and major pathogens were also 
retrieved. 
 Additionally, 19 investigators listed as authors on papers addressing this topic were contacted 
in order to identify any unpublished or difficult to locate studies related to the question of interest. 
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Only one additional narrative review was identified by this route. Only manuscripts relating to mastitis 
pathogens of the bovine were included, and papers needed to specifically deal with IMI caused by 
minor pathogens (as opposed to teat apex colonization, for instance) and NIMI caused by major 
pathogens (as opposed to clinical mastitis without delineation of pathogen type, etc.).  
 
Data Extraction 
 A set of 3 structured data collection forms (based on Sargeant et al., 2006) were devised and 
used for extraction of information. One form addressed general information given in the paper, a 
second included specific questions relating to the study type described, and a third form provided a 
structure for extraction of the outcomes and raw data given in the manuscripts. Two independent 
investigators read and extracted information simultaneously. The data extraction forms were initially 
tested on 5 included papers and changes for clarity were addressed. Any differences in data extraction 
were discussed by the investigators, and consensus was reached after further referring to the paper in 
question. If a paper reported more than one set of observations for separate minor or major pathogens, 
each pairing of pathogens was reported separately. If a paper reported the effect of a minor pathogen 
on a combined group of major pathogens (e.g. CNS vs. S. aureus, S. uberis and S. dysgalactiae), or 
when raw data were presented that allowed this grouping to be performed, these data were also 
extracted independently. Although results from studies reporting by treatment groups (e.g. lactational 
therapy groups, post-milking teat disinfection trials, etc.) were recorded separately when details were 
provided in the manuscript, these were often combined in the meta-analysis due to inadequate group 
sizes for comparison.  
 Descriptive, study design and study quality information extracted from each study are listed in 
Table 1. Challenge studies and observational studies also had individual information relevant to their 
study design extracted. 
 If presented in individual manuscripts, quarter-level data were used to construct 2x2 tables for 
use in the meta-analysis. These raw data were available for all but 2 papers detailing challenge 
experiments and all but 8 papers reporting observational findings. Four manuscripts presented odds 
ratios (OR) - one unadjusted from a case-control analysis (Lam et al., 1997), and 3 adjusted from 
multilevel models (Green et al., 2002; Green et al., 2005; Schukken et al., 1999) ± and either standard 
errors (SE) or 95% confidence intervals, from which SE could be calculated. Three references (Hogan 
et al., 1988; Woolford et al., 2001; Zadoks et al., 2001a) reported rates of new infections, and others 
reported differing measures such as median difference of infection at the herd level (Michel et al., 
2011), clinical differences (Spencer et al., 1968), and coefficients from Poisson models (Zadoks et al., 
 6 
2001b). Data from these last 6 papers were not able to be included in the meta-analysis, although, as 
selections for the systematic review, reported outcomes are discussed later in this manuscript.  
 A number of manuscripts presented results for multiple minor and major pathogens, so 
individual study values were constituted using the raw data or reported OR. Studies from observational 
papers representing a number of different data collections (on lactating cows versus dry cows, for 
instance) were represented separately. Exceptions to this occurred when there appeared to be no 
substantial differences between the trials or the researchers themselves combined data in the original 
publication. Many challenge studies reported differing pathogens and amounts of pathogens used in 
challenges; these data were extracted as separate studies where sufficient detail was reported.    
   
Meta-analyses 
 A number of meta-analyses were carried out in order to investigate the effect of minor 
pathogen IMI on the acquisition of NIMI with major pathogens (Table 2).  
x Manuscripts differed in the individual pathogens investigated, so a general meta-analysis 
comparing the effect of both minor pathogens (CNS and C. bovis) on acquisition of NIMI with 
any major pathogens (S. aureus, S. agalactiae, S. uberis, S. dysgalactiae, Escherichia coli, and 
other pathogens such as Klebsiella spp. or environmental streptococci) was initially performed.  
x Studies were then grouped as observational or challenge studies, and a meta-analysis within 
each group was performed.  
x Separate meta-analyses investigating the effects of CNS and C. bovis individually on all major 
pathogens were also performed.  
x The effects of each minor pathogen on acquisition of NIMI with S. aureus were also 
investigated in separate meta-analyses.  
 Due to identification of a high degree of heterogeneity among studies, random effects meta-
analyses using the method described by DerSimonian and Laird (1986) were performed. Odds ratios 
were selected as the measure of association in order to incorporate the results of the 4 papers not 
containing raw data but reporting OR and SE or 95% confidence intervals. In order to calculate OR for 
those [WDEOHVZLWKFHOOVFRQWDLQLQJWKHYDOXHµ¶DQHPSLULFDOFRQWLQXLW\FRUUHFWLRQZDVHPSOoyed, 
as this is expected to decrease the amount of bias in estimation of effect in the subsequent meta-
analyses (Sweeting, et al., 2004). 
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Meta-regressions 
 Meta-analysis regressions, or meta-regressions, were employed to investigate the reasons for 
heterogeneity among studies. These analyses use data summarized at the study level to fit regression 
models with the natural log of the OR (lnOR) as the outcome variable.  
x Firstly, all predictors described in Table 1 were investigated for their contribution to 
heterogeneity using univariable meta-regressions.  
x Next, predictors of interest as well as those showing association 35 before Bonferroni 
correction) with the lnOR were combined in multivariable meta-regressions when the number 
of studies available made this possible.  
x Separate meta-regressions were fit for datasets involving any minor pathogen and any major 
pathogen, observational studies only, challenge studies only, CNS and major pathogens, C. 
bovis and major pathogens, CNS and S. aureus, and C. bovis and S. aureus. 
 There were often such a small number of studies included ± especially in the individual CNS 
and C. bovis effects on S. aureus meta-regressions ± that multivariable meta-regressions were not 
possible. Factors were initially combined with the 3-level study design variable and assessed for 
further significance. Those that appeared to provide much the same information as study design 
(collinear) or were expected to be caused by study design (intervening) were not included in further 
modeling (Table 1). Multivariable models were then built using a manual stepwise procedure in an 
attempt to account for the most between-study heterogeneity while maintaining statistical significance 
3 in the predictors. Factors within the multivariable model were also assessed for collinearity to 
make sure they were not representing the same information. Adjusted-R2 values were used to indicate 
the relative reduction in the between-study variance (Harbord and Higgins, 2008). In order to avoid 
Type I errors occurring due to inclusion of multiple predictors in the multivariable meta-analyses, a 
random permutation test based on Monte Carlo simulation was used to provide a multiplicity 
adjustment of the P-values (Harbord and Higgins, 2008). To provide sufficient precision, the command 
was set to 20,000 permutations, and results were compared to those obtained in the multivariable 
models. 
 
Publication Bias or Small-Study Effects 
 A funnel plot was generated in order to evaluate the presence of publication bias or small-study 
effects. This plot sets the odds ratio against its standard error, thereby displaying the differences among 
effects of smaller studies and those of larger studies (Harbord et al., 2009). Lack of symmetry in the 
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plot suggests that bias may be present, or that small studies with large standard errors may be 
influencing the estimate of the effect size(JJHU¶VWHVWIRUDV\PPHWU\ZDVFKRVHQIURPDPRQJWKH
possible options and applied to evaluate the evidence for publication bias or small-study effects 
(Harbord et al., 2009).  All analyses were conducted using Stata 12IC (StataCorp, College Station, 
TX). 
 
RESULTS 
 
Literature Search 
 The literature search identified 267 abstracts which were further investigated for relevance to 
the topic. After removal of manuscripts that did not include information relating to infection with 
minor and major mastitis pathogens, did not specify bacteriological interaction, reported effects of 
minor pathogens without any information regarding major pathogen IMI, or did not directly address 
the specific question under investigation (Figure 1), 38 manuscripts containing the results of 69 studies 
met the selection criteria for inclusion in the meta-analysis (Appendix 1). Of these, 35 were published 
in peer-reviewed journals, 2 came from conference proceedings, and one was a thesis.  
 
Descriptive Information 
 The papers included represented a wide range of research conducted over 6 decades in a 
number of countries. Descriptive information here is provided for all papers, while information related 
specifically to the studies included in the meta-analysis is listed in Table 1. Papers often contained a 
number of trials or observations about different minor and major pathogens. Manuscripts reported 
results of analyses involving what they termed CNS, coagulase-negative micrococci or simply 
micrococci. These have been combined here and are referred to as CNS. Twenty-nine papers contained 
studies examining minor pathogen effects on NIMI with S. aureus (12 with CNS only, 11 with C. bovis 
and 6 with both), while 13 papers contained studies with S. agalactiae as the outcome (6 with CNS, 6 
with C. bovis and 1 with both). Fifteen papers presented results of major infections with coliform 
bacteria (5 with CNS, 6 with C. bovis, 4 with both). Studies were conducted in the UK (n=9), the US 
(n=8), Sweden (n=5), Canada (n=5), France (n=3), the Netherlands (n=3), New Zealand (n=2), 
Denmark (n=1), Finland (n=1), and Switzerland (n=1). Holstein cattle were mainly used, followed by 
Jersey cattle and other dairy breeds (Swedish Red and White, Guernsey, Friesian, Meuse-Rhine-Yssel).  
Total number of cows was often small for challenge studies (median=19, mean=64.5), although one 
multi-year challenge trial included 600 cows (Nickerson and Boddie, 1994), and papers often detailed 
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the results of a number of challenge studies conducted on subsets of cows. Observational studies were 
much larger in terms of total cows (median=255, mean=673.4). A variety of definitions for IMI were 
found among the papers, with diagnostic criteria from 20 cfu/mL to 350 cfu/mL and some papers 
requiring that IMI be present in consecutive samples, duplicate samples, or in samples from cows 
diagnosed with clinical mastitis in order to be considered infected. These were categorized into 4 
variables, 2 each for minor and major pathogen definitions: a threshold category (<100 cfu/mL, 100-
29FIXP/DQGFIXP/DQGDGLDJQRVLVclassification (whether or not IMI needed to be 
diagnosed in consecutive, duplicate, or clinical mastitis samples). A subjective assessment of whether 
the conclusions of the authors were supported by the results presented in the paper was made by the 
data extractors.  
 All but one manuscript describing challenge experiments were included in the meta-analysis. 
Spencer et al. (1968) gave a general impression that no effect of minor pathogens was elicited, but did 
not report any data that were usable in further analyses. Of the remaining 16 papers reporting challenge 
experiments, 37 studies were compiled. Of these, challenge studies were separated into categories: 
µFKDOOHQJH-FKDOOHQJH¶VWXGLHVZKHUHTXDUWHUVZHUHFKDOOHnged with a minor pathogen and then 
challenged with a major pathogen (n=17µQDWXUDO-FKDOOHQJH¶VWXGLHVZKHUHTXDUWHUVZHUHQDWXUDOO\
infected with minor pathogens before being challenged with major pathogens (n=9DQGµERWK-
FKDOOHQJH¶VWXGLHVZKHUHVRPH quarters were naturally infected with minor pathogens and some were 
challenged with the same minor pathogen (to increase numbers in the minor-pathogen IMI group), then 
all were challenged with a major pathogen (n=9) (Figure 1). There were 2 studies that included 
quarters challenged with a minor pathogen (CNS) and then observed for natural infection with a major 
pathogen (Pankey et al., 1985), but these were combined with the observational study group, as 
challenge with a major pathogen was believed to be the basis for an experimental challenge study 
(Figure 1). Twenty-two of the challenge studies involved CNS as the minor pathogen, and 15 
challenge studies investigated the effects of C. bovis.   
 Of the 21 papers detailing observational work, 5 did not contain data that could be used in the 
meta-analysis (Figure 1). Hogan et al. (1988) reported rates of infection with minor and major 
pathogens, but extracting raw data from the information given was not possible. Michel et al. (2011) 
included only median differences of minor and major pathogen infections between herds and estimated 
a protective effect based on herd profile. Woolford et al. (2001) summarized a higher incidence of S. 
uberis infection in quarters infected with C. bovis, but did not provide any information with which to 
extract any further data. Zadoks et al. (2001b) reported a higher incidence of S. uberis in quarters 
infected with other pathogens (including minor pathogens) and also reported parameters in Poisson 
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models (2001a), but this information could not be transformed into a format for meta-analysis. The 
other 16 manuscripts comprised 31 usable individual studies. Of these, 11 reported on the effects of 
CNS, and 20 represented the effects of C. bovis IMI.  
  In total, 69 studies were extracted from the 38 manuscripts. One study failed to find any major 
pathogen NIMI, and as such was not expected to contribute to the overall meta-analysis (Sweeting et 
al., 2004), so it was removed, leaving 68 usable studies (Figure 1). 
 
Meta-analyses 
 Due to the extreme heterogeneity among studies in these meta-analyses, the values obtained for 
the estimates of overall OR cannot be expected to accurately represent the effect of minor pathogen 
IMI on the acquisition of NIMI with major pathogens. Overall measures of effect are reported, but 
readers are cautioned that these overall measures may be of limited use due to the substantial 
differences among the studies included in these meta-analyses. 
 The estimated effects of minor pathogen IMI on acquisition of major pathogen NIMI are given 
in Table 2 and are illustrated in forest plots in Figures 2, 3 and 4 (separated by type of study). A 
significant protective effect was seen for the effects of all minor pathogens on acquisition of NIMI 
with all major pathogens. Since study design was expected to be a major contributor to the 
heterogeneity among studies, it was broken down into subgroups and analyzed separately. A 
significant protective effect was present in challenge studies; there was no effect seen amongst 
observational studies (Table 2). There was considerable between-study heterogeneity (Ĳ2), most 
QRWDEO\LQWKHµFKDOOHQJH-FKDOOHQJH¶VWXGLHV (Table 2, Figure 3).  
 A sensitivity analysis was conducted on the full dataset by removing studies individually and 
assessing change in effect. No one study was influential enough to alter the OR estimate from the 
statistically significant protective range (data not shown). Removal of all 12 studies by the research 
group of Linde et al., however, shifted the overall OR estimate to 0.84 (95% CI=0.65, 1.10), a 
statistically non-significant effect (P=0.20).   
 
Meta-regressions 
 A specific aim of this research was to describe and quantify the heterogeneity among studies 
that exists in the literature in order to identify areas of difference that might explain the divergent 
effects of minor pathogens reported through the years. Univariable meta-regressions revealed that a 
number of predictors had significant influence on the OR estimates, even when a Bonferroni correction 
was applied (Table 1).  
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 Minor Pathogens and Study Design. There was little evidence of the presence of either CNS 
or C. bovis contributing to the heterogeneity in OR among studies in the dataset including both minor 
pathogens (P=0.09, adjusted R2=-0.4%), therefore this variable was not included in further 
multivariable meta-regressions. Overall, ORs in challenge studies were significantly lower than those 
found in observational studies (P=0.01). In order to further delineate the nature of this relationship, the 
categories of challenge studies were separated; this increased the R2 to 37.9%, and showed that the 
majority of the difference LQHIIHFWFDPHIURPWKHµERWK-FKDOOHQJH¶ studies, those where quarters were 
challenged with minor pathogens or could be naturally infected with minor pathogens before major 
pathogen challenge. 6WXGLHVLQWKHµERWK-FKDOOHQJH¶FDWHJRU\ZHUHVLJQLILFDQWO\PRUHOLNHO\WRVKRZD
protective effect of minor pathogens (P<0.001) compared to observational studies; compared to no 
HIIHFW25 µERWK-FKDOOHQJH¶VWXGLHVZere more likely to show substantial protection (OR=0.06). 
6WXGLHVLQWKHµQDWXUDO-FKDOOHQJH¶FDWHJRU\ZHUHDOVRVLJQLILFDQWO\PRUHOLNHO\WRVKRZSURWHFWLRQ
(P=0.04, protection of OR=0.33 compared to no effect), ZKLOHWKH25VRIµFKDOOHQJH-FKDOOHQJH¶VWXGLHV
were not predicted to be significantly different from those generated by observational studies. Ten of 
WKHVWXGLHVLQWKHµERWK-FKDOOHQJH¶JURXSZHUHFRQGXFWHGE\RQHUHVHDUFKJURXS (Linde et al.), 
however, and the overall methods of this research group were believed to account for the majority of 
these differences. Since all of these studies had animals that were challenged with a minor pathogen, 
these µERWK-FKDOOHQJH¶VWXGLHVZHUHFRPELQHGZLWKWKHµFKDOOHQJH-FKDOOHQJH¶JURXSWRIRUPD-
level categorical variable for study design REVHUYDWLRQDOµFKDllenge-FKDOOHQJH¶DQGµQDWXUDO-
FKDOOHQJH¶. As this set of variables was believed to confound the relationship between the outcome 
and a number of other predictors in the analyses, this representation of study design was forced into all 
multivariable meta-regression models.  
 Underlying Risk. Underlying risk refers to risk of the outcome (here, a NIMI with a major 
pathogen) in the population of bovine quarters not infected with minor pathogens, and accounts for a 
number of unmeasured variables in a population. There was significant variation in the underlying risk 
among studies - 48 different values ranging from an odds of 0.01 to 36.2 were calculated - and 
underlying risk was a significant predictor in unconditional analysis. Since underlying risk is 
inherently related to the OR, the use of meta-regression alone for evaluation of its contribution to 
heterogeneity is not adequate (Dohoo et al., 2007). To further evaluate the effect of heterogeneity due 
to underlying risk, a recommended maximum likelihood random slopes model was fit and compared to 
the outcomes from standard meta-UHJUHVVLRQ7KLVPRGHOUHVXOWHGLQDFRHIILFLHQWHVWLPDWHȕYHU\
FORVHWRWKHYDOXHRIȕHVWLPDWHGE\VWDQGDUGPHWD-UHJUHVVLRQȕ -0.45, SE=0.06 in recommended 
PRGHOȕ -0.50, SE=0.06 in meta-regression). Since this value was in close agreement and was not 
 12 
PXFKOHVVWKDQWKHELDVLQHVWLPDWLRQRIWKHRXWFRPHDQGRIȕE\VWDQGDUGWRROVZDVDVVXPHGWREH
small, and the use of standard meta-regression was deemed sufficient (Dohoo et al., 2007). 
 As underlying risk in a study increased, the amount of protection due to minor pathogens 
estimated by that study also increased. Underlying risk was seen to be much lower in observational 
studies (mean odds of major pathogen NIMI in quarters not infected with minor pathogens = 1.8) as 
RSSRVHGWRµFKDOOHQJH-FKDOOHQJH¶VWXGLHVPHDQRGGV= RUµQDWXUDO-challenJH¶VWXGLHVPHDQRGGV
= 10.0). Underlying risk was not significantly associated with the outcome in observational studies. 
Underlying risk was a significant predictor in challenge studies, however, with a similar level of effect 
in both µFKDOOHQJH-FKDOOHQJH¶and µQDWXUDO-FKDOOHQJH¶VWXGLHV 
 Unconditional Analyses of Other Factors. A number of study-level factors proved to be 
significant predictors of the heterogeneity among studies in unconditional analyses. Because of the 
multiple comparisons made, Bonferroni correction should be applied in order to decrease Type I error, 
and P-values were divided by 34 in order to evaluate significance (only factors with P-values <0.0015 
would be considered statistically significant). A number of predictors would have been significant after 
Bonferroni correction or were close enough to significance to be of specific interest. Table 1 provides 
an overview of the factors investigated, their unconditional associations with the outcome and the 
amount of variation explained by each factor.   
 Briefly, the odds of a study finding an increased risk of major pathogen NIMI caused by minor 
pathogen IMI increased through the years, and the season in which the study took place was 
significant, although the major difference was among studies performed over all 4 seasons and those 
that did not declare in which season they were performed (mainly those that were short trials). These 
shorter studies were more likely to find a protective effect of minor pathogens than were studies 
conducted over a longer period of time. Studies conducted on a combination of research and 
commercial farms found significantly more risk of minor pathogen IMI than studies conducted either 
on commercial farms, and there were no significant differences among studies conducted on research 
farms and those conducted on commercial operations (P=0.07), although there was a trend for studies 
on research facilities to find protection. Studies that took samples more often were more likely to find a 
protective effect of minor pathogens. Requiring that minor or major pathogen IMIs be found in 
duplicate samples, consecutive samples or in samples from cows diagnosed with clinical mastitis (a 
more stringent requirement for IMI diagnosis than just finding it in single samples) was associated 
with an increased likelihood to identify minor pathogen IMI as risk factors. Studies that failed to report 
loss of study subjects to follow-up were also more likely to find increased risk associated with minor 
pathogen IMI than were studies that did report loss to follow-up (P=0.001). 
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 Multivariable Model. Eighteen of the 34 factors assessed by unconditional analyses had 
3EHIRUH%RQIHUURQLcorrection, so were investigated further in multivariable meta-regressions 
(Table 1). A multivariable model with study design, minor pathogen IMI definition and breed was built 
which explained 58.0% of the between-study heterogeneity (Ĳ2 reduced from 1.67 to 0.70; Table 3). 
µ&KDOOHQJH-FKDOOHQJH¶VWXGLHVZHUHVLJQLILFDQWO\ more likely to find protection than observational 
studiesDVZHUHµQDWural-FKDOOHQJH¶VWXGLHV. Studies where minor pathogen IMI was only diagnosed if 
the minor pathogen appeared in duplicate samples, consecutive samples or in samples from quarters 
with clinical mastitis (as opposed to single samples) were significantly more likely to show increased 
risk of major pathogen NIMI by minor pathogen IMI. A similar effect was also seen for studies in 
which major pathogen NIMI was stringently defined, but these 2 variables were very collinear and the 
effect was greater for minor pathogens, so the minor pathogen variable was included in the 
multivariable model. In order to avoid Type I errors occurring due to inclusion of multiple predictors 
in the multivariable meta-analysis, a random permutation test based on Monte Carlo simulation was 
used to provide a multiplicity adjustment of the P-values (Harbord and Higgins, 2008). To provide 
sufficient precision, the command was set to 20,000 permutations and results were compared to those 
REWDLQHGLQWKHPXOWLYDULDEOHPRGHOµ&KDOOHQJH-FKDOOHQJH¶DQGµQDWXUDO-FKDOOHQJH¶studies remained 
significantly different from observational studies (P=0.001 and P=0.04 respectively), and diagnosis of 
minor pathogen IMI requiring duplicate, consecutive or clinical mastitis was still significantly different 
from diagnosis on single samples alone (P=0.009). The P-value for the increased risk for studies 
conducted on Jerseys as compared to Holsteins became borderline significant (P=0.07).       
 Underlying risk was not included in the above model as it was believed to be an intervening 
variable, coming between the role of study design and the outcome (lnOR) on the causal pathway. In 
order to build a model representing the role study design played, therefore, underlying risk could not 
be included. Underlying risk was, however, believed to account for much of the heterogeneity in the 
outcome, so adding it to a multivariable model was of interest. Study design also needed to be included 
in such a model as it was believed to have a confounding effect on the underlying risk. Another 
multivariable model was built including underlying risk, therefore, that was able to account for 81.7% 
of heterogeneity among studies (data not shown). This model was similar to the model presented in 
Table 3, but breed was found to be associated with underlying risk in simple linear regression, so was 
not included. The true effect of study design was obscured in this model, although the effect of minor 
pathogen IMI diagnosis was relatively unchanged. This model revealed that, as the risk of a major 
pathogen NIMI in quarters not infected with a minor pathogen increased, the odds of such a study 
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identifying overall risk for major pathogen NIMI decreased (i.e. studies with higher underlying risk 
found more protective effects of minor pathogens; OR 0.61 compared to no effect, P<0.001). 
 Factors Specific to Observational and Challenge Studies. Because of their intrinsic 
differences, certain factors relating specifically to challenge studies and observational studies were 
evaluated separately. Studies where cows were housed in conditions similar to those in the field were 
more likely to identify risk caused by minor pathogens than those that did not describe housing 
conditions, but this result was not significant when a Bonferroni correction was applied, nor was it 
significant in further multivariable model building. This indicates that differences among observational 
studies can be mostly explained by factors that were common to both observational and challenge 
studies (Table 1). A number of exclusive predictors were significant for challenge studies, however, 
and in unconditional analyses appeared to explain a significant portion of the heterogeneity among 
studies. Studies that included cows naturally infected with minor pathogens in challenge studies were 
more likely to identify a protective effect of minor pathogens than studies using uninfected cows 
(P<0.001). Studies that did not report whether or not they tested cows prior to major pathogen 
challenge were also more likely to find a protective effect of minor pathogens (P=0.03). Route of 
administration of minor and major pathogens was also significantly associated with the outcome. 
Studies where minor or major pathogens were administered via immersion of the teat in an infective 
broth (teat dip) reported less protection than those involving direct infusion of minor pathogens into 
the teat (intra-cisternal injection or cannulation into the teat cistern or teat duct) (P<0.001). As the 
interval between minor pathogen diagnosis and major pathogen challenge increased, the amount of 
protection afforded by minor pathogen IMI decreased (P<0.001).   
 PUHGLFWRUVWKDWZHUHVLJQLILFDQW3LQXQFRQGLWLRQDODQDO\VHVEHIRUH%RQIHUURQL
correction) were evaluated for collinearity with study design using tabulation for categorical predictors 
and simple linear regression for continuous predictors. All predictors that were not collinear with study 
design retained their significance (Table 1). These predictors were evaluated for collinearity with one 
another, then entered into multivariable models in a stepwise fashion in order to achieve a maximum of 
R2 while maintaining statistical significance for the predictors. A model explaining 66.3% of the 
heterogeneity between studies resulted, which contained study design, major pathogen dose, and 
whether or not a study adequately reported the challenge protocols (Table 4). Study design was not 
significant in unconditional analyses among challenge studies, nor was it significant in the 
multivariable model. In studies utilizing major pathogen >500 cfu/mL doses, the amount of protection 
afforded by minor pathogen IMI was decreased (lnOR increased). Studies that did not report the dose 
of major pathogen used in experimental challenge also showed a decreased amount of protection 
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compared to studies that used the smaller dose. Studies that did not adequately report challenge 
protocols were all smaller studies (<40 cows) and showed overall more protective effect of minor 
pathogens on acquisition of NIMI with major pathogens (lnOR decreased). The random permutation 
multiplicity adjustment was also applied to this model at a setting of 20,000 permutations, and the P-
value for the reporting of challenge protocols remained significant (P=0.02), as did the difference seen 
between non-reporting of major pathogen challenge dose vs. the lower dose (P=0.005).  
 Data Subsets. Many of the same factors were significant in meta-regressions for the data 
subsets (CNS and all major pathogens, C. bovis and all major pathogens, CNS and S. aureus, C. bovis 
and S. aureus), although it was more difficult to build multivariable meta-regression models for these 
subsets due to the smaller numbers of studies. Of note was that the threshold for diagnosis with either a 
minor pathogen or major pathogen was a significant predictor of the outcome in the data subset for 
CNS with all major pathogens, even when modeled with study design. These 2 variables accounted for 
44.0% of the heterogeneity between studies. Similar to previous results, challenge studies showed 
more protection than observational studies. Studies that used a liberal diagnosis for IMI or NIMI (<100 
cfu/mL) were more likely to identify a protective effect of minor pathogens (OR decreased to 0.30 
compared to no effect3 WKDQWKRVHXVLQJFIXP/DVZHUHVWXGLHVWKDWGLGQRWVSHFLI\WKH
threshold used for diagnosis with IMI (OR decreased to 0.18 compared to no effect, P=0.01). 
Publication Bias or Small-study Effects.  
 Funnel plots were generated and used to visually assess the evidence for publication bias or 
small-study effects (Figure 5). Study size (and therefore study standard error) was confounded by 
study type, so observational studies and challenge studies were assessed separately. The graph for 
observDWLRQDOVWXGLHVORRNHGURXJKO\V\PPHWULFDOGDWDQRWVKRZQDQGWKH(JJHU¶VWHVWIRUIXQQHOSORW
asymmetry gave little evidence for small study effects (P=0.31). Challenge studies were distributed 
more on the left side of the graph (Figure 5), however, with 2 small studies showing protective effects 
of minor pathogens and large standard errors being evident in the left lower quadrant. No small studies 
showing increased risk of minor pathogens were seen in the corresponding right lower quadrant. 
Studies of moderate size were identified in the right middle of the plot, but substantially more 
moderately-sized studies existed in the left middle. 7KH(JJHU¶VWHVWindicated evidence for small study 
effects (p=0.04) when only challenge studies were assessed. An attempt to impute estimates for types 
of studies that might be missing from the literature review µWULPDQGILOO¶PHWKRG resulted in no 
changes to the data (Steichen, 2000). 
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DISCUSSION 
 
 A wide variety of literature pertaining to minor and major mastitis pathogen interaction exists. 
The studies selected for this meta-analysis, however, pertain specifically to minor pathogen IMI and its 
effects on the acquisition of major pathogen NIMI. During the literature search, a number of papers 
addressing questions of somatic cell count differences, duration of major pathogen infections in 
quarters previously or concomitantly infected with minor pathogens, morphological changes in the 
mammary gland after minor and major pathogen infections and the effects of minor pathogens not 
specifically causing IMI (e.g. on teat apices) were also identified. Although research in these areas also 
provides insight into the effects of minor pathogens in the bovine udder, these studies did not address 
the specific research question set for the analyses presented here. As such, these types of investigations 
and the information they contain can be used to augment work such as that presented here to provide 
further insight into the interactions between minor and major pathogens. 
 
Meta-analyses 
 It is emphasized again that, due to the large amount of heterogeneity among these studies, 
estimation of an overall effect of minor pathogens has limited utility. The meta-analyses presented here 
do suggest overall, however, that minor pathogens have a protective effect against NIMI with major 
pathogens. When broken down further, this effect was drawn from the results of challenge studies, as 
the result for observational studies is very close to the value for no effect and is not statistically 
significant (Table 2). Challenge studies, then, seem to overwhelmingly show more protection by minor 
pathogens, for reasons to be discussed below. Studies that could not be included in the meta-analysis 
because they did not report OR report differing effects, with Spencer et al. (1968), Hogan et al. (1988), 
Woolford et al. (2001), and Zadoks et al. (2001a, 2001b) all showing either an increase or no 
difference in the major pathogen infection in quarters infected with minor pathogens. The paper by 
Michel et al. (2011) describes higher prevalence of CNS in herds with lower prevalence of S. aureus, 
which might be inferred as protection by CNS against S. aureus. 
 The effects of the minor pathogens when separated are somewhat less clear. CNS shows a 
strong protective effect against the major pathogens, while for C. bovis this is less pronounced and 
does not achieve statistical significance. As many authors have suggested, there are undoubtedly 
differences in the effects of the minor pathogens on the differing major pathogens, although this 
becomes more difficult to sort out because total numbers of studies for major pathogens other than S. 
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aureus are low and, because of this low power, analyses are unable to show differences beyond what 
might be attributed to chance. 
 A number of protective mechanisms of minor pathogens have been investigated and/or 
suggested. Non-specific activation of the immune system through host defense mechanisms such as 
increase in somatic cell count and differential cell count have been investigated and play a role in the 
interplay between pathogens in the bovine udder (Schukken et al., 1999; Pyörälä and Taponen, 2009). 
Production of bacteriocins and other inhibitory substances by minor pathogens have been suggested, as 
have stimulation of anti-staphylococcal antibody production by the host, alteration of fatty acid 
concentration, and general inhibition of major pathogen passage through the teat canal (Brooks and 
Barnum, 1984; Nickerson and Boddie, 1994; Schukken et al., 1999; Pyörälä and Taponen, 2009). 
These are all plausible explanations for the protection evidenced by the results presented here, however 
it is beyond the scope of these analyses to suggest the reasons behind the protective effects or to lend 
credence to any particular theory.  
 
Underlying Risk 
 Dohoo et al. (2007) have shown that, even with an underlying risk coefficient equal to -2, the 
amount of bias in the outcome achieved by standard meta-analysis is limited. Since the recommended 
maximum likelihood random slopes model gave coefficient estimates comparable to those given by 
standard meta-regression, this value was assumed to be accurate. Underlying risk accounted for a large 
amount of the heterogeneity among studies; its inclusion in a multivariable model resulted in an 
increase in the amount of heterogeneity explained by the model (e.g. adjusted-R2 rose from 58.0% to 
81.7%). Underlying risk may be a surrogate for the unmeasured factors contributing to variations in 
study populations (Dohoo et al., 2007), so its accounting for a significant proportion of the 
heterogeneity is not surprising. Although this paper sought to evaluate sources of heterogeneity among 
the included studies, there are still many factors that remain unaccounted for. 
  
Meta-regressions 
 In unconditional associations (Table 1), the amount of heterogeneity accounted for by each of 
these predictors is substantial, with a total in excess of 100%, as many of them are representing the 
same information (they are collinear). Because of this collinearity, many of the predictors that were 
significantly associated with the outcome in unconditional analyses could not be included in the 
multivariable model.  
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 Although study design was not found to account for much of the between-study heterogeneity 
(adjusted-R2= 7.8%) in unconditional analysis, it was significant in the multivariable model, where 
ERWKµFKDOOHQJH-FKDOOHQJH¶DQGµQDWXUDO-FKDOOHQJH¶VWXGLHVIRXQGPRUHSURWHFWLRQE\PLQRUSDWKRJHQV
than observational studies. It has been noted that challenge studies often bypass the natural defenses of 
the teat (teat orifice, keratin plug, etc.) as pathogens are infused directly into either the teat canal or teat 
cistern. In these studies, WKHPDMRULW\RIµQDWXUDO-FKDOOHQJH¶VWXGLHV9) had major pathogens 
administered directly into the teat, ZKLOHDPRQJµFKDOOHQJH-FKDOOHQJH¶VWXGLHVWKHUHZDVPRUHYDULDWLRQ
(7 into the teat, 10 by immersion and 9 that did not specify a route). The only challenge studies that 
identified minor pathogens as risk factors for major pathogen NIMI, however, were those that 
administered major pathogen via teat immersion. This was also found in unconditional analyses: 
studies infusing major pathogens into the teat (either by intra-cisternal injection or cannulation) 
identified minor pathogens as having much more of a protective effect than studies using teat 
immersion (OR decreased to 0.09 as compared to no effect, P<0.001) or observational studies (OR 
decreased to 0.15 as compared to no effect, P<0.001). This relationship also held true in the data 
subsets for CNS and all major pathogens (OR decreased to 0.05 compared to teat dip or observational 
studies, P<0.001 for both) and for CNS and S. aureus (OR decreased to 0.05 compared to teat dip, 
P=0.007; OR decreased to 0.03 compared to observational studies, P=0.001), but was borderline 
significant in the data subset for C. bovis and all major pathogens (OR for infused teats decreased to 
0.18, P=0.05; observational studies showed no difference, P=0.23) and completely non-significant in 
the data subset with C. bovis and S. aureus. This predictor alone represented >87% of the 
heterogeneity among studies in both the CNS and C. bovis major pathogen data subsets.  
 It has been proposed that activity at the teat end makes the difference in penetration and 
eventual NIMI occurrence with major pathogens. A number of authors have suggested that minor 
pathogens break down teat defenses or interfere with the keratin plug, allowing major pathogens to 
penetrate and initiate infection (Hogan et al., 1988; Williamson et al., 1995; Zadoks et al., 2001b; 
Berry and Hillerton, 2002a and 2002b). It has also been shown that the presence of subclinical mastitis 
aids in the growth of major pathogens in the udder by the release of nutrients necessary for their 
survival (Mattila et al., 1984; Mattila and Sandholm, 1986; Kitt and Leigh, 1997). It may be that minor 
pathogens are protective against major pathogens once inside the udder, although they also may 
increase susceptibility to major pathogens accessing the udder tissue. If minor pathogens are indeed 
operating in different ways in different parts of the udder, this might explain why many challenge 
studies using infusion of major pathogens identify protection while challenge studies using teat 
immersion and observational studies (in which major pathogens must access the udder via the teat end) 
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often identify increased risk or no effect of minor pathogen IMI on acquisition of new major pathogen 
NIMI. 
 The protective effect of minor pathogen IMI on acquisition of major pathogen NIMI was more 
likely to be seen in studies that utilized a more lenient definition of when an IMI exists or when a 
NIMI occurs. This was evident not only in IMI definitions in the larger dataset but also in IMI 
threshold restrictions in the data subset with CNS and major pathogens. Stringent requirements for 
defining when an IMI exists or when a NIMI occurs mean that the specificity of diagnosis will be high, 
but at the cost of reduced sensitivity. Hence, although false positive diagnoses are minimized, false 
negative diagnoses will increase. Low sensitivity of bacteriological culture for the majority of 
pathogens has already been reported (Dohoo et al., 2011), and it is therefore possible that many of 
these studies underestimated the presence of minor pathogens and missed the occurrence of major 
pathogen NIMIs. This misclassification bias undoubtedly affected the associations presented in these 
studies. Since the same sampling and bacteriological methods were applied to samples from cows with 
and without minor pathogen infection, it is assumed that the misclassification would be non-
differential and, therefore, that the associations would be biased towards the null, meaning they may 
be, in fact, underestimated.  
   Challenge studies utilizing higher doses of major pathogens for challenge and those that did not 
report the dosages used showed minor pathogen IMI to afford less protection against major pathogen 
NIMI. It is intuitive that a larger inoculum of major pathogen would more easily overcome any 
protective effect offered by minor pathogens, although this logic perhaps cannot be extended to studies 
that did not report the major pathogen dosage. Interestingly, studies without adequate descriptions of 
challenge protocols found more evidence for protection by minor pathogens than those with full 
descriptions of the protocols used. Many of these studies did not report significant details such as the 
route of challenge administration, method of allocation of quarters to be challenged or the time 
between challenge and sampling for diagnosis of NIMI. Although inadequate reporting of details such 
as these does not necessarily mean that studies were not conducted appropriately, it does call into 
question the repeatability of the studies and the overall methods by which conclusions were reached.  
 The majority of studies either did not report the season in which they were conducted (27/68) 
or were conducted over all 4 seasons (39/68). Studies not reporting the season are likely to have been 
conducted over a short period of time (days or weeks instead of an entire year), and were more likely 
to find a protective effect of minor pathogens. Studies not reporting season were also associated with 
more frequent sampling of quarters. Although minor pathogens have been shown to cause chronic 
infections in the udder (Honkanen-Buzalski et al., 1984; Pyörälä and Taponen, 2009), it may be that 
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they exhibit more of a protective effect over a short period of time than over long periods. Another 
possible explanation is that studies conducted over long periods of time may culture minor pathogens 
at the beginning of the study period (before dry-off, for instance) instead of identifying these pathogens 
very close to the time of major pathogen NIMI.  
 Sampling frequency was closely related to study design but, like publication year, seemed to 
account for a greater proportion of the heterogeneity among studies (29.3% vs. 7.8%). It is difficult to 
attribute an observed effect of minor pathogen IMI on major pathogen NIMI to the presence of minor 
pathogen IMI cultured 10-20 weeks prior to the occurrence of a NIMI, although this is what some 
manuscripts offered. Studies conducted over the dry period also identified minor pathogens prior to 
drying off and related their presence to the occurrence of major pathogen NIMI after calving, usually 6 
or more weeks later. Minor pathogen infections may become chronic, but this cannot be assumed of all 
minor pathogen IMI during all stages of lactation, and conclusions from studies sampling over very 
long periods should be drawn with care.  
 
Publication Bias or Small-study Effects 
 The lack of studies showing high levels of risk caused by minor pathogen IMI may be an 
indication of publication bias (small studies showing increased risk of minor pathogens have not been 
published) or of small-study effects (smaller studies showed very protective effects of minor 
pathogens). In Figure 5, there are only 2 small studies showing very protective effects of minor 
pathogens, and one small observational study also showed very protective effects (data not shown). 
Studies with moderate sample size and estimates of increased risk are included (right central area of 
the plot), although there are more moderately sized studies that show protection (left central area). 
There are approximately the same number of studies showing increased risk (right) in the upper 
portion of the plot compared to studies showing protection (left).  If bias is present, however, and small 
or moderate studies showing increased risk of major pathogen NIMI caused by minor pathogens do 
exist, inclusion of these studies would serve to move the estimate of minor pathogen effect closer to 
the null. Another explanation is that the moderately-sized studies showing protective effects are 
driving the estimate of effect towards protection. The studies represented in this middle left portion of 
the funnel plot ranged between 4 and 40 cows. Although this relationship was not evident in the 
univariable meta-regression with number of cows, this may be partially because the representation of 
number of cows was difficult, and most closely approximated a quadratic relationship with the 
outcome. It can be seen in Figure 5, however, that the majority of the smaller and moderately-sized 
studies showed a protective effect of minor pathogens. When studies were grouped according to 
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QXPEHURIFRZVDQG!those involving more cows were seen to show more risk for minor 
pathogens (OR increased to 6.0 compared to no effect, P<0.001) and 35.3% of the heterogeneity 
among studies was explained. This parameter could not be included in multivariable models, however, 
since it was collinear with study design. 
 Although it may not be possible to conduct experimental studies on large numbers of animals, 
smaller studies such as these may suffer from a lack of rigorous scientific methods. In the data 
presented here, all challenge studies judged to have inadequate protocols were studies with fewer than 
40 cows. The one study that was judged to have inadequate time between pathogen challenge and 
subsequent diagnosis and 2 studies that failed to describe this amount of time were also smaller 
studies.  Smaller studies also may not utilize fully the statistical tools available to account for 
occurrences such as interdependence, cow-level effects or confounders. In these data, the 8 studies 
reporting estimates adjusted for risk factors other than minor pathogen infection were all >40 cows, as 
were all 6 studies where multilevel modeling was used to account for interdependence between 
quarters, cows and herds.  
 (JJHU¶VWHVWIRUVPDOOVWXG\HIIHFWVZDVVLJQLILFDQWIRUFKDOOHnge studies, but not for 
observational studies. This is not surprising, as small study effects were suspected on visual 
interpretation of the graph of challenge studies, and it is known that all tests proposed to evaluate small 
study effects may give falsely positive results in the presence of extreme study heterogeneity (Harbord 
et al., 2009). The authors emphasize again that this excessive heterogeneity also calls into question the 
accuracy of the estimate of effect given by the meta-analysis. 
 
Other Considerations 
 In order to maximize power and detect significant differences in the meta-analyses and meta-
regressions, the 2 groups of minor pathogens and a number of major pathogen groups were combined. 
Although this approach makes it possible to delineate differences that may not be seen with fewer data, 
it certainly has drawbacks as it is not expected that these pathogens all behave in the same manner in 
nature. Certainly speciation of the group of pathogens referred to as CNS would be beneficial as 
different species exhibit a range of chronicity and inflammatory effects in the mammary gland (Supré 
et al., 2011). Some attempts to further examine the effects of individual minor pathogens on major 
pathogens were made, but resulted in non-significant outcomes, most likely due to low power.  
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Conclusions 
 In conclusion, a wide body of evidence exists on the subject of minor pathogen IMI and its 
effect on the acquisition of major pathogen NIMI. Significant heterogeneity among studies exists, 
some of which could be accounted for using meta-regression. The analyses presented here reveal that, 
overall, challenge studies showed strong and significant protective effects, specifically when major 
pathogens were introduced into the mammary gland by methods which by-passed the teat end. 
Observational studies were not associated with either a protective effect or increased risk of major 
pathogen NIMI. Underlying risk can account for a number of unmeasured factors in studies, and was 
significant in all challenge studies, revealing an inverse relationship with the outcome. Larger doses of 
challenge organisms reduced the protective effect of minor pathogens, and studies with more stringent 
diagnostic criteria for pathogen IMI also identified less protection. As the interval between infection 
with a minor pathogen and challenge with a major pathogen increased, less protection was identified, 
and studies in which samples were taken less frequently also demonstrated less protection.  Smaller 
studies also showed a greater protective effect than larger studies. The data suggest that, for a number 
of reasons, minor pathogens might seem more protective under artificial conditions than in real-world 
circumstances. 
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Table 1. Descriptive, study design and study quality information extracted from each of 68 studies included in the meta-analysis 
investigating the effect of CNS and Corynebacterium bovis intramammary infections on acquisition of new intramammary infections with 
major pathogens. Both unconditional associations from univariable meta-regressions with major pathogen infection and the association 
observed after controlling for study design in multivariable meta-regressions are reported.  
 
   
Unconditional1 w/ study design2 
Variable n3 Description P-value R2 4 P-value R2 
Descriptive information       
   Publication year 68 (range: 1965-2012)  0.0015 21.6 Collin.6  
   Publication source 68 Peer-reviewed, proceedings, other 0.08   5.3   
   Country 68 North America, Europe, other 0.05   1.4 0.02 15.9 
   Breed 68 Holstein, Jersey, other 0.02   6.1 <0.0001 43.5 
   Season 68 Spring, winter, all, ND7    0.0001 28.6 Collin.  
   Underlying risk (odds of disease) 60 (range: 0.01-36.2)  <0.001 69.3 Interv.8  
   Total farms 61 (range: 1-91) 0.27  -1.59   
   Total cows 55 (range: 2-6825) ± represented as quadratic 0.008 15.8 0.29 44.7 
   No. cows +minor  17 (range: 2-18)  NS10 --   
   No. cows +major 23 (range: 2-220) NS --   
   No. qtrs +minor 64 (range: 2-13,504) 0.40  -2.3   
   No. qtrs +major 68 (range: 1-346) 0.42  -2.6   
       
Study design information       
   Study design 68 Observational, challenge (challenge-
challenge11, natural-challenge12) 
0.04 7.8   
   Minor pathogen 68 CNS, C. bovis 0.09   -0.4 0.26 7.6 
   Farm type 68 Commercial farm(s), research facility, both  0.004   20.0 Col  
   Parity 68 Heifers, multiparous cows, both, ND 0.99  -8.0   
   Stage of lactation 68 Dry period only, lactation only, both  0.01 13.3 Col  
   Sampling frequency 60 Samples/week (range: 0.06-7.5) <0.001 29.3 Col  
   Sampling method 68 Single, duplicate samples 0.62  -3.4   
   IMI definition ± minor 68 Required duplicate, consecutive, or clinical 
mastitis for diagnosis: yes, no, ND 
 <0.0001 40.5 <0.0001 50.1 
   IMI threshold - minor 68 3 categories of cfu/mL, ND 0.04   0.2 0.02 12.6 
   IMI definition ± major 68 Required duplicate, consecutive, or clinical 
mastitis for diagnosis: yes, no, ND 
   0.0001 27.1 <0.0001 48.9 
 29 
   IMI threshold - major 68 3 categories of cfu/mL, ND 0.06   0.1 0.01 14.7 
   Used dry cow therapy? 68 All, some none, ND, NA13   0.004 22.6 Collin.  
   Dry cow therapy 68 Antibiotics, teat sealant, ND, NA    0.005 21.3 Collin.  
   Post-milking teat dip 68 All, some none, ND 0.05   3.8 0.0006 26.9 
       
 Study quality       
   Specific objective of study? 68 Yes, no 0.10   4.2   
   Justified sample size? 68 Yes, no 0.03   7.8 0.09 11.3 
   Loss to follow-up reported? 68 Yes, partial, no   0.004 12.6 0.007 17.7 
   % lost to follow-up 10 (range 0-21%) NS --   
   Conclusions supported by results? 68 Yes, no 0.36  0.4   
   Effect measure 68 Unadjusted, adjusted for other predictors 0.66 -1.9   
   Statistical control for clustering 68 Yes, no 0.53 -1.1   
   Confounders controlled  68 Parity, stage of lactation, other, none 0.89 -5.9   
       
Challenge studies only       
   Protocols adequately described? 37 Yes, no   0.00214 29.2 0.001 29.3 
   Experimental unit - minor 37 Some qtrs, NA 0.89  -3.5   
   Experimental unit ± major 37 All qtrs, some qtrs 0.92  -3.3   
   Challenge allocation ± minor 37 Simple random, blocked random, systematic, 
ND, NA 
0.07 24.8   
   Challenge allocation ± major 37 Simple random, systematic, ND, NA 0.85  -9.3   
   Inclusion of previously infected 
   qtrs  
37 All neg., neg. major,  pos. minor or major, not 
tested  
  0.002 41.5 Collin.  
   Challenge administration ± minor 37 Intra-cisternal, cannulation into teat 
duct/cistern, dip, ND, NA  
 <0.0001 67.5 Collin.  
   Challenge administration ± major 33 Intra-cisternal, cannulation into teat 
duct/cistern, dip, ND, NA 
   0.0001 61.4 0.0001 57.1 
   Pathogen dose ± minor 28 FIX!FIX1'    0.0001 60.4 Collin.  
   Pathogen dose ± major 37 FIX!FIX1'  0.001 47.9 0.002 39.4 
   Minor dx to major chal. interval 33 (range: 2-303 days) <0.001 60.7 <0.001 60.5 
   Sufficient interval for dx? 37 Yes, no, ND 0.84   -4.2   
          
Observational studies only       
   Representative housing? 31 Yes, ND    0.0415 13.9   
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   Farm selection 31 Convenience, purposive, random, ND 0.40  5.4   
   Indicate farm reason to decline?  31 Indicated, not indicated, single farm 0.28   4.9   
   Inclusion/exclusion criteria  31 Described, not described 0.30   5.6   
1Values provided for univariable meta-regression analyses with single predictor 
2Values provided for multivariable meta-regression analyses with predictor and 3-level variable for study design (only variables with 
unconditional P-YDOXHVEHIRUH%RQIHUURQLFRUUHFWLRQZHUHHYDOXDWHGIXUWKHU 
3Number of studies included 
4Adjusted-R2=value of heterogeneity between studies accounted for by this predictor (amouQWRIYDULDQFHĲ2) accounted for by the model)  
534 predictors evaluated, so P-values of unconditional associations <0.0015 would be considered significant using Bonferroni method for 
multiple comparisons 
6Variable represented much the same information as study design (collinear) 
7ND = not described 
8Variable causes the outcome but occurs between study design and the outcome (intervening) 
9R2 values <0 may occur when the predictor explains less variation than would be expected by chance (Harbord and Higgins, 2008) 
10Reported by too few studies to give sensible values in meta-regression 
11Challenge studies where quarters were experimentally challenged both with a minor pathogen and subsequently with a major pathogen 
12Challenge studies where quarters were naturally infected with a minor pathogen and challenged with a major pathogen 
13NA = not applicable 
1416 predictors evaluated, so P-values of unconditional associations <0.003 would be considered significant using Bonferroni method for 
multiple comparisons 
154 predictors evaluated, so P-values of unconditional associations <0.01 would be considered significant using Bonferroni method for 
multiple comparisons 
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Table 2. Estimated effects from separate meta-analyses of minor pathogen intramammary infection 
(IMI) on acquisition of new intramammary infections (NIMI) with major pathogens  
 
 n1 OR 95% CI P Ĳ2 2 
Any minor pathogen/ Any major pathogen 68 0.68 0.52, 0.88 0.003 0.65 
    Observational studies 31 1.02 0.75, 1.39 0.89 0.46 
    Challenge studies 37 0.36 0.23, 0.59 <0.001 1.22 
        Challenge-challenge studies3 28 0.31 0.15, 0.66 0.002 3.11 
        Natural-challenge studies4  9 0.38 0.22, 0.67 0.001 0.25 
CNS/Major pathogen 33 0.52 0.35, 0.77 0.001 0.65 
C. bovis/Major pathogen 35 0.81 0.52, 1.17 0.26 0.80 
CNS/S. aureus 21 0.57 0.33, 0.99 0.05 0.98 
C. bovis/S. aureus 16 0.57 0.34, 0.94 0.03 0.69 
1Number of studies included 
2Between-study variance in OR (heterogeneity among studies) 
3Challenge studies where quarters were experimentally challenged both with a minor pathogen and 
subsequently with a major pathogen 
4Challenge studies where quarters were naturally infected with a minor pathogen and challenged with a 
major pathogen 
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Table 3. Multivariable meta-regression model to explain heterogeneity among 68 studies on the effect 
of minor pathogen intramammary infection on acquisition of new intramammary infections with major 
pathogens. The table includes odds ratios (OR), 95% confidence interval, P-values and the between-
VWXG\YDULDQFHRUKHWHURJHQHLW\Ĳ2). 
 
Variable OR 95% CI P Ĳ2 
Null model 0.55 0.38, 0.81 0.003 1.67 
Multivariable model    0.70 
   Intercept 0.53 0.24, 1.15 0.11  
   Study type     
     Observational study Baseline    
      µ&KDOOHQJH-FKDOOHQJH¶VWXG\ 0.15 0.07, 0.35 <0.001  
      µ1DWXUDO-FKDOOHQJH¶VWXG\ 0.19 0.07, 0.54 0.002  
   IMI definition, minor path.     
      Based on single sample Baseline    
      Based on duplicate, consecutive or 
          clinical mastitis samples 
4.66 1.95, 8.50 <0.001  
      Not described 1.22 0.45, 3.32 0.69  
   Breed     
      Holstein Baseline    
      Jersey 4.66 1.68, 12.94 0.004  
      Other 0.88 0.41, 1.88 0.90  
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Table 4.  Multivariable meta-regression model to explain heterogeneity among 37 challenge studies on 
the effect of minor pathogen intramammary infection on acquisition of new intramammary infections 
with major pathogens. The table includes odds ratios (OR), 95% confidence interval, P-values and the 
between-study vDULDQFHRUKHWHURJHQHLW\Ĳ2). 
 
Variable OR 95% CI P Ĳ2 
Null model   0.32 0.17, 0.59 0.001 2.34 
Multivariable model    0.80 
   Intercept   0.20 0.08, 0.54 0.002  
   Study type     
      µ&KDOOHQJH-FKDOOHQJH¶VWXG\ Baseline    
      µ1DWXUDO-challenge¶VWXG\   1.31 0.41, 4.18 0.64  
   Dose of major pathogen administered      
      FIXP/ Baseline    
      >500 cfu/mL   3.71 1.27, 10.91 0.02  
      Not described 11.94 3.25, 44.26 0.001  
   Description of challenge protocols     
      Adequately described Baseline    
      Inadequately described   0.15 0.05, 0.44 0.001  
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Figure 1. Flow chart detailing inclusion, exclusion and categorization of manuscripts and studies 
included in the systematic review. Reasons for inclusion/exclusion are provided at each step of the 
systematic review. 
Figure 2. Forest plot displaying a random-effects meta-analysis of the effect of CNS and 
Corynebacterium bovis intramammary infections on acquisition of new intramammary infections with 
major pathogens for observational studies. Lengths of horizontal lines represent 95% confidence 
intervals (CI) for the effect, black dots represent the individual OR estimates of the studies and gray 
squares are proportional to the weight given to each study. The dashed line represents the overall effect 
of all the studies (OR=1.02), while the solid line represents the value for no effect (OR=1). The 
diamond at the bottom of the dashed line represents the 95% CI for the overall effect of the 
observational studies (0.75, 1.39). 
Figure 3. Forest plot displaying a random-effects meta-analysis of the effect of CNS and 
Corynebacterium bovis intramammary infections on acquisition of new intramammary infections with 
major pathogens for µFhallenge-FKDOOHQJH¶VWXGLHV/HQJWKVRIKRrizontal lines represent 95% 
confidence intervals (CI) for the effect, black dots represent the individual OR estimates of the studies 
and gray squares are proportional to the weight given to each study. The dashed line represents the 
overall effect of all the µFKDOOHQJH-challenge studies (OR=0.31), while the solid line represents the 
value for no effect (OR=1). The diamond at the bottom of the dashed line represents the 95% CI for the 
overall effect RIWKHµFKDOOHQJH-FKDOOHQJH¶VWXGLHV(0.14, 0.66). 
Figure 4. Forest plot displaying a random-effects meta-analysis of the effect of CNS and 
Corynebacterium bovis intramammary infections on acquisition of new intramammary infections with 
PDMRUSDWKRJHQVIRUµQatural-FKDOOHQJH¶VWXGLHV/HQJWKVRIKRUL]RQWDOOLQHV represent 95% confidence 
intervals (CI) for the effect, black dots represent the individual OR estimates of the studies and gray 
squares are proportional to the weight given to each study. The dashed line represents the overall effect 
RIDOOWKHµQDWXUDO-FKDOOHQJH¶VWXGLHV25 ZKLOHWKHVROLGOLQHUHSUHVHQWVWKHYDOXHIRUQRHIIHFW
(OR=1). The diamond at the bottom of the dashed line represents the 95% CI for the overall effect of 
WKHµQDWXUDO-FKDOOHQJH¶VWXGLHV 
Figure 5. Funnel plot of the individual study OR estimates for the effect of CNS and Corynebacterium 
bovis intramammary infections on acquisition of new intramammary infections with major pathogens 
for challenge studies. Small-study effects are evidenced by the presence of numerous studies with 
small OR (x-axis) and large standard errors (y-axis) on the left hand side of the plot. 
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Figure 4. 
NOTE: Weights are from random effects analysis
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Figure 5.   
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Appendix 1. Overview and descriptive information of 38 manuscripts comprising 68 studies used in 
meta-analyses examining the effect of minor pathogen intramammary infection on new intramammary 
infections with major pathogens 
 
Reference (year) Study 
design1 
Min. 
path.2 
Major pathogens3 n4 Parity5 Stage6  
Aarestrup and Jensen (1997) O CNS SA, SU, SD 180 H lact 
Berry and Hillerton (2002a) I7 O CNS SA, SU, coli 290 nd dry 
Berry and Hillerton (2002a) II O CB SA, SU, coli 290 nd dry 
Berry and Hillerton (2002b) I O CNS SA, SU, coli 401 nd dry 
Berry and Hillerton (2002b) II O CB SA, SU, coli 401 nd dry 
Black et al. (1972) I O CB SA 32 nd lact 
Black et al. (1972) II O CB Sag, SU, SD, oth 32 nd lact 
Black et al. (1972) III O CB coli, oth 32 nd lact 
Black et al. (1972) IV O CB coli, oth 38 nd lact 
Black et al. (1972) V O CB SA 38 nd lact 
Black et al. (1972) VI O CB SAg, SU, SD, oth 38 nd lact 
Bramley (1975) O CB  SA, SAg, SU, SD, coli nd8 nd both 
Bramley (1976) I NC CNS coli 6 H+L lact 
Bramley (1976) II NC CNS coli 4 H+L dry 
Bramley (1978) CC CNS SAg, coli 17 nd lact 
Brooks et al. (1983) O CB SA, SAg, SU, SD, coli, oth       nd H+L both 
Brooks and Barnum (1984) I CC CB SA 32 nd lact 
Brooks and Barnum (1984) II CC CB SA 32 nd lact 
Brooks and Barnum (1984) III CC CB SAg 32 nd lact 
Brooks and Barnum (1984) IV CC CB SAg 32 nd lact 
Davidson et al. (1992) O CNS SA 84 L lact 
Doane et al. (1987) I NC CB SU 18 nd lact 
Doane et al. (1987) II NC CB SU 4 nd lact 
Green et al. (2002) I O CB SA, SAg, SU, SD, coli, oth 480 nd both 
Green et al. (2002) II O CB SA, SAg, SU, SD, coli, oth 480 nd both 
Green et al. (2005) I O CNS SA 480 nd dry 
Green et al. (2005) II O CB SA 480 nd dry 
Green et al. (2005) III O CB SU 480 nd dry 
Honkanen-Buzalski et al. (1984) I O CB SA, SAg, SU, SD, coli, oth 1450 nd both 
Honkanen-Buzalski et al. (1984) II O CB SA, SAg, SU, SD, coli, oth 1450 nd both 
Lam et al. (1997) I O CNS SA, SU, SD, coli 392 nd both 
Lam et al. (1997) II O CB SA, SU, SD, coli 392 nd both 
Linde et al. (1975a) CC CNS SA 9 nd lact 
Linde et al. (1975b) I CC CNS SA, SAg, SD 14 nd lact 
Linde et al. (1975b) II CC CNS SAg, SD 5 nd lact 
Linde et al. (1976) I CC CNS SA 6 nd lact 
Linde et al. (1976) II CC CNS SAg, SU, SD 7 nd lact 
Linde et al. (1980) I CC CNS SA 8 nd lact 
Linde et al. (1980) II  CC CNS SAg, SU, SD 7 nd lact 
Linde et al. (1980) III  CC CNS Coli, oth 9 nd lact 
Linde et al. (1980) IV CC CB SA, SD 2 nd lact 
Linde (1982) I CC CNS SA 8 nd lact 
Linde (1982) II CC CNS SAg, SU, SD 7 nd lact 
Linde (1982) III CC CNS Coli, oth 9 nd lact 
Matthews et al. (1990) NC CNS SA 10 nd lact 
Matthews et al. (1991) O CNS SA, SU, SD, coli, oth 113 H+L both 
Myllys (1995) O CNS SA, SU, SD, oth 50 H dry 
Newbould et al. (1965) NC CB SA 10 H+L lact 
 41 
Nickerson and Boddie (1994) NC CNS SA, SAg 600 nd lact 
Pankey et al. (1985) I CC CB SA       57 nd lact 
Pankey et al. (1985) II CC CNS SA       57 nd lact 
Pankey et al. (1985) III CC CB SA       nd nd lact 
Pankey et al. (1985) IV CC CNS SA       nd nd lact 
Pankey et al. (1985) V CC CB SA       nd nd lact 
Pankey et al. (1985) VI  CC CNS SA       nd nd lact 
Pankey et al. (1985) VII CC CB SAg       nd nd lact 
Pankey et al. (1985) VIII CC CNS SAg       nd nd lact 
Pankey et al. (1985) IX CC CB SAg       nd nd lact 
Pankey et al. (1985) X CC CNS SAg       nd nd lact 
Pankey et al. (1985) XI O CB SU       nd nd dry 
Parker et al. (2007) O CNS SA, SU, SD, coli, oth 255 H dry 
Postle et al. (1978)  NC CB SA 41 H+L lact 
Poutrel and Lerondelle (1980) CC CNS SA 44 H lact 
Rainard and Poutrel (1988) I O CNS SA, SAg, SU, SD 122 H+L lact 
Rainard and Poutrel (1988) II O CB SA, SAg, SU, SD 122 H+L lact 
Reyher et al. (2012) I O CNS SA, SU, SD, coli 6825 H+L lact 
Reyher et al. (2012) II O CB SA, SU, SD, coli 6825 H+L lact 
Schukken et al. (1999) NC CB SA 145 H+L lact 
1Study design: observational (O), challenge studies where quarters were experimentally challenged both with a minor 
pathogen and subsequently with a major pathogen (CC), challenge studies where quarters were naturally infected with a 
minor pathogen and challenged with a major pathogen (NC) 
2Minor pathogens represented: coagulase-negative staphylococci (CNS), Corynebacterium bovis (CB) 
3Major pathogens represented: Staphylococcus aureus (SA), Streptococcus agalactiae (SAg), Streptococcus uberis (SU), 
Streptococcus dysgalactiae (SD), coliforms (coli), other streptococci, Pseudomonas spp., yeast, etc. (oth) 
4Number of cows 
5Parity: Heifers only (H), lactating cows only (L), heifers and lactating cows (H+L), not described (nd) 
6Stage of lactation: Lactation only (lact), dry period only (dry), both lactation and dry period (both) 
7Study number from a single reference 
8Not described (nd) 
 
